Skip to main content

Hauptrubriken

CME
Facharzt-Training
Webinare
Zeitschriften
Bücher
e.Medpedia
Podcast

Service

Jobbörse
Info & Hilfe

Fachgebiete

Anästhesiologie
Allgemeinmedizin
Arbeitsmedizin
Augenheilkunde
Chirurgie
Dermatologie
Gynäkologie und Geburtshilfe
HNO
Innere Medizin
Kardiologie
Neurologie
Onkologie und Hämatologie
Orthopädie und Unfallchirurgie
Pädiatrie
Pathologie
Psychiatrie
Radiologie
Rechtsmedizin
Umweltmedizin
Urologie
Zahnmedizin

Themen

Neues aus dem Markt
COVID-19
Praxis und Beruf
Seltene Erkrankungen
GOÄ & EBM
Panorama

Sammlungen

Kasuistiken
Algorithmen & Infografiken
Blickdiagnosen
Videos
Kongressberichte
Medizin für Apothekerinnen und Apotheker
Für Ärztinnen und Ärzte in Weiterbildung
Für Medizinstudierende
Erweiterte Suche
Login
nach oben
Die Ophthalmologie
Erschienen in: Die Ophthalmologie 1/2021

23.07.2020 | Glaukom | Leitlinien, Stellungnahmen und Empfehlungen

Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms

Leitlinie von DOG und BVA

verfasst von: Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie | Sonderheft 1/2021

Einloggen, um Zugang zu erhalten

Auszug

Diese Leitlinie betrachtet Risikofaktoren für das Auftreten eines Offenwinkelglaukoms bei Erwachsenen und schätzt ab, inwieweit diese Risikofaktoren regelmäßige Untersuchungen zur Erkennung eines Offenwinkelglaukoms notwendig machen. Das Offenwinkelglaukom ist definiert als „chronisch progressive Optikusneuropathie, die als gemeinsame Merkmale morphologische Veränderungen der Papille und der retinalen Nervenfaserschicht aufweisen, ohne dass andere okuläre Erkrankungen oder kongenitale Anomalien vorliegen. Diese Veränderungen gehen mit einem progressiven Untergang der Axone retinaler Ganglienzellen und mit einem progressiven Gesichtsfeldverlust einher“ [ 1]. Eine Erkrankung am Offenwinkelglaukom wird von Patienten oft erst im fortgeschrittenen Stadium bemerkt, bei dem bereits irreversible Gesichtsfelddefekte vorliegen (s. Abschn. 1 Krankheitsbild). …
Literatur
1.
European Glaucoma Society (2014) Terminology and guidelines for glaucoma, 4. Aufl. PubliComm, Milano
2.
Wang D et al (2017) Ethnic differences in lens parameters measured by ocular biometry in a cataract surgery population. PLoS ONE 12(e0179836):6
3.
4.
5.
Crabb DP et al (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120(6):1120–1126 PubMed
6.
Weih LM et al (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108(11):1966–1972 PubMed
7.
Kawasaki R et al (2013) Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study. Ophthalmology 120(1):84–90 PubMed
8.
Mukesh BN et al (2002) Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 109(6):1047–1051 PubMed
9.
Czudowska MA et al (2010) Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 117(9):1705–1712 PubMed
10.
de Voogd S et al (2005) Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 112(9):1487–1493 PubMed
11.
Cedrone C et al (2012) The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study. J Glaucoma 21(1):1–6 PubMed
12.
Hitzl W et al (2006) The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5‑year incidences in this prospective, population-based longitudinal study. Klin Monbl Augenheilkd 223(12):970–973 PubMed
13.
Astrom S, Stenlund H, Linden C (2007) Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 85(8):832–837 PubMed
14.
Pan CW et al (2017) Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese. Am J Ophthalmol 176:127–133 PubMed
15.
Kim YK et al (2014) Five-year Incidence of Primary Open-Angle Glaucoma and Rate of Progression in Health Center-Based Korean Population: The Gangnam Eye Study. PLoS One 9(12):e114058. PubMed
16.
Levkovitch-Verbin H et al (2014) The Maccabi Glaucoma Study: prevalence and incidence of glaucoma in a large israeli health maintenance organization. Am J Ophthalmol 158(2):402–408.e1 PubMed
17.
Vijaya L et al (2014) Predictors for incidence of primary open-angle glaucoma in a South Indian population: the Chennai eye disease incidence study. Ophthalmology 121(7):13706
18.
Varma R et al (2012) Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol 154(2):315–325.e1 PubMedPubMedCentral
19.
Leske MC et al (2007) Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114(6):1058–1064 PubMed
20.
Leske MC et al (2001) Incidence of open-angle glaucoma: the Barbados Eye Studies. Arch Ophthalmol 119(1):89–95 PubMed
21.
Lin CC, Hu CC, Ho JD et al (2013) Obstructive sleep apnea and increased risk of glaucoma: a population-based matched-cohort study. Ophthalmology 120(8):1559–1564 PubMed
22.
Tham YC et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081–2090 PubMed
23.
Hohn R et al (2018) Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 256(9):1695–1702 PubMed
24.
Ramdas WD et al (2011) Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci 52(9):6875–6881 PubMed
25.
Ekstrom C (2012) Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study. Acta Ophthalmol 90(4):316–321 PubMed
26.
Le A et al (2003) Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 44(9):3783–3789 PubMed
27.
Tielsch JM et al (1994) Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 112(1):69–73 PubMed
28.
Mitchell P et al (2002) Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study. Ophthalmic Epidemiol 9(5):333–345 PubMed
29.
Kapetanakis VV et al (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100(1):86–93 PubMed
30.
Kass MA et al (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701–713
31.
Cook JA et al (2012) Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 119(8):1552–1557 PubMed
32.
Reiter C, Gramer E, Gramer G (2012) Pseudoexfoliation syndrome: no central zone of pseudoexfoliation material in patients with pseudophakia—a clinical study. Klin Monbl Augenheilkd 229(3):241–245 PubMed
33.
Quigley HA et al (2001) The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 119(12):1819–1826 PubMed
34.
Varma R et al (2004) Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111(8):1439–1448 PubMed
35.
Alward WL et al (1998) Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 338(15):1022–1027 PubMed
36.
Fingert JH et al (1999) Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 8(5):899–905 PubMed
37.
Rezaie T et al (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295(5557):1077–1079 PubMed
38.
Monemi S et al (2005) Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 14(6):725–733 PubMed
39.
Thorleifsson G et al (2007) Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317(5843):1397–1400 PubMed
40.
Thorleifsson G et al (2010) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 42(10):906–909 PubMedPubMedCentral
41.
Burdon KP et al (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet 43(6):574–578 PubMed
42.
Gharahkhani P et al (2014) Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet 46(10):1120–1125 PubMedPubMedCentral
43.
Ahmadi N et al (2015) Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology 53(4):290–302 PubMed
44.
Alfano JE (1963) Changes in the Intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247 PubMed
45.
Armaly MF (1963) Effect of Corticosteroids on Intraocular pressure and fluid dynamics. I. The effect of Dexamethasone in the normal eye. Arch Ophthalmol 70:482–491 PubMed
46.
Becker B, Mills DW (1963) Corticosteroids and Intraocular pressure. Arch Ophthalmol 70:500–507 PubMed
47.
Bernstein HN, Schwartz B (1962) Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol 68:742–753 PubMed
48.
Kiddee W et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58(4):291–310 PubMed
49.
Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106(12):2301–2306 PubMed
50.
Valenzuela CV et al (2019) Intranasal Corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope 129(1):6–12 PubMed
51.
Marcus MW et al (2012) Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging 29(12):963–970 PubMed
52.
Hollands H et al (2013) Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 309(19):2035–2042 PubMed
53.
Crowston JG et al (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88(6):766–770 PubMedPubMedCentral
54.
Mitchell P et al (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103(10):1661–1669 PubMed
55.
Gupta P et al (2016) Prevalence of glaucoma in the United States: the 2005–2008 national health and nutrition examination survey. Invest Ophthalmol Vis Sci 57(6):29052913
56.
Zhao D et al (2015) Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology 122(1):72–78 PubMed
57.
Zhao YX, Chen XW (2017) Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. Int J Ophthalmol 10(9):1430–1435 PubMedPubMedCentral
58.
59.
Zhao D et al (2014) The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol 158(3):615–627.e9 PubMed
60.
Ko F et al (2016) Diabetes, triglyceride levels, and other risk factors for glaucoma in the national health and nutrition examination survey 2005–2008. Invest Ophthalmol Vis Sci 57(4):2152–2157 PubMedPubMedCentral
61.
Deva NC et al (2008) Risk factors for first presentation of glaucoma with significant visual field loss. Clin Experiment Ophthalmol 36(3):217–221 PubMed
62.
Heijl A, Bengtsson B, Oskarsdottir SE (2013) Prevalence and severity of undetected manifest glaucoma: results from the early manifest glaucoma trial screening. Ophthalmology 120(8):1541–1545 PubMed
63.
Gramer G, Gramer E (2018) Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability. Int Ophthalmol 38(2):429–441 PubMed
64.
Bengtsson B, Heijl A (2016) Lack of visual field improvement after initiation of Intraocular pressure reducing treatment in the early manifest glaucoma trial. Invest Ophthalmol Vis Sci 57(13):5611–5615 PubMedPubMedCentral
65.
Caprioli J, Coleman AL (2008) Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 115(7):1123–1129.e3 PubMed
66.
Garway-Heath DF et al (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385(9975):1295–1304 PubMed
67.
Li T et al (2016) Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123(1):129–140 PubMed
68.
Leske MC et al (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121(1):48–56
69.
Leske MC et al (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114(11):1965–1972 PubMed
70.
Heijl A et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120(10):1268–1279 PubMed
71.
72.
Vessani RM et al (2009) Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 18(3):253–261 PubMed
73.
Abrams LS et al (1994) Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 101(10):1662–1667 PubMed
74.
Jonas JB et al (2000) Ranking of optic disc variables for detection of glaucomatous optic nerve damage. Invest Ophthalmol Vis Sci 41(7):1764–1773 PubMed
75.
Wang F et al (1998) Evaluation of screening schemes for eye disease in a primary care setting. Ophthalmic Epidemiol 5(2):69–82 PubMed
76.
Katz J, Sommer A (1990) Screening for glaucomatous visual field loss. The effect of patient reliability. Ophthalmology 97(8):1032–1037 PubMed
77.
Tuck MW, Crick RP (1997) The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 4(1):3–17 PubMed
78.
Tielsch JM et al (1991) A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 134(10):1102–1110 PubMed
79.
Baptista AM et al (2010) Evaluation of discomfort of Goldmann tonometry without anaesthetic. Ophthalmic Physiol Opt 30(6):854–859 PubMed
80.
Heijl A et al (2009) Natural history of open-angle glaucoma. Ophthalmology 116(12):2271–2276 PubMed
81.
Wilson MR (2002) Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies. Trans Am Ophthalmol Soc 100:365–410 PubMedPubMedCentral
82.
Rotchford AP et al (2012) Day-to-day variability in intraocular pressure in glaucoma and ocular hypertension. Br J Ophthalmol 96(7):967–970 PubMed
83.
Coleman DJ, Trokel S (1969) Direct-recorded intraocular pressure variations in a human subject. Arch Ophthalmol 82(5):637–640 PubMed
84.
Mauger RR, Likens CP, Applebaum M (1984) Effects of accommodation and repeated applanation tonometry on intraocular pressure. Am J Optom Physiol Opt 61(1):2830
85.
Malihi M, Sit AJ (2012) Effect of head and body position on intraocular pressure. Ophthalmology 119(5):987–991 PubMed
86.
87.
88.
Tran T et al (2014) Rise of intraocular pressure in a caffeine test versus the water drinking test in patients with glaucoma. Clin Experiment Ophthalmol 42(5):427–432 PubMed
89.
Sit AJ (2014) Intraocular pressure variations: causes and clinical significance. Can J Ophthalmol 49(6):484–488 PubMed
90.
Sales CS et al (2014) Open-angle glaucoma in Filipino and white Americans: a comparative study. J Glaucoma 23(4):246–253 PubMed
91.
92.
Metadaten
Titel
Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms
Leitlinie von DOG und BVA
verfasst von
Deutsche Ophthalmologische Gesellschaft (DOG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum
23.07.2020
Verlag
Springer Medizin
Schlagwort
Glaukom
Erschienen in
Die Ophthalmologie / Ausgabe Sonderheft 1/2021
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-020-01169-4

Weitere Artikel der Sonderheft 1/2021

Die Ophthalmologie 1/2021 Zur Ausgabe

Leitlinien, Stellungnahmen und Empfehlungen

Leitlinie Nr. 24a Uveitis intermedia

Leitlinien, Stellungnahmen und Empfehlungen

Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema

Leitlinien, Stellungnahmen und Empfehlungen

Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration

Erratum

Erratum zu: Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms

Leitthema

Eye changes in space

Leitlinien, Stellungnahmen und Empfehlungen

Statement of the German Society of Ophthalmology, the German Retina Society, and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity

Neu im Fachgebiet Augenheilkunde

02.03.2023 | Basalzellkarzinom | Leitthema

Chirurgische Exzision von Lidtumoren und anschließende ophthalmoplastische Rekonstruktionen

23.02.2023 | Glaukom | CME

Glaukom im Säuglings- und Kindesalter

17.02.2023 | Basalzellkarzinom | Leitthema

SOP-Lidtumoren

10.02.2023 | Nävi | Leitthema

Diagnose und Therapie der benignen Lidtumoren
» zur Themenseite Augenheilkunde rotated-square